approval · primary record
ETRIPAMIL
FDA · NDA · 2025-12-12
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-12-12 |
| Brand | CARDAMYST |
| Sponsor | MILESTONE PHARMS USA |
| Route | NASAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:14.227Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ETRIPAMIL:2025-12-12
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.